GCC’s 29 initial public offerings (IPOs) have raised $6.8 billion in the first nine months (9M) of 2023, marking a year-on-year decline in value of 56% compared to 9M of 2022, when issuers raised $15.6 billion through 30 offerings.
The global saudi arabia pharmaceutical market is predicted to be worth US$ 13,000 Million by the end of 2032 to grow at an incredible 9.6% CAGR from 2022 to 2032, which will present a significant opportunity. The market is anticipated to be worth US$ 5,209.5 million by the end of 2022.Due to the country’s fast incre.